These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1997015)

  • 1. Risk factors and manifestations of digoxin toxicity in the elderly.
    Wofford JL; Ettinger WH
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):11-5; discussion 33-4. PubMed ID: 1997015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which cardiac disturbances should be treated with digoxin immune Fab (ovine) antibody?
    Marchlinski FE; Hook BG; Callans DJ
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):24-8; discussion 33-4. PubMed ID: 1997018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poisoning in the elderly. Epidemiological, clinical and management considerations.
    Klein-Schwartz W; Oderda GM
    Drugs Aging; 1991 Jan; 1(1):67-89. PubMed ID: 1794007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of clinical experience with digoxin immune Fab (ovine).
    Smith TW
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):1-6; discussion 33-4. PubMed ID: 1997014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of age-related differences in the clinical presentation of digoxin toxicity.
    Wofford JL; Hickey AR; Ettinger WH; Furberg CD
    Arch Intern Med; 1992 Nov; 152(11):2261-4. PubMed ID: 1444686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of the use of digoxin immune Fab (ovine) for treatment of digoxin toxicity.
    Mauskopf JA; Wenger TL
    Am J Cardiol; 1991 Dec; 68(17):1709-14. PubMed ID: 1746476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of digoxin intoxication in a renal failure patient with digoxin-specific antibody fragments and plasmapheresis.
    Rabetoy GM; Price CA; Findlay JW; Sailstad JM
    Am J Nephrol; 1990; 10(6):518-21. PubMed ID: 2075910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the management of digoxin toxicity in the older patient.
    Borron SW; Bismuth C; Muszynski J
    Drugs Aging; 1997 Jan; 10(1):18-33. PubMed ID: 9111705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitalis toxicity. Using immunotherapy when supportive care isn't enough.
    Krisanda TJ
    Postgrad Med; 1992 May; 91(6):273-8, 281-4. PubMed ID: 1579534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-specific Fab and therapeutic plasma exchange for digitalis intoxication and renal failure.
    Pellegrino M; Garofalo M
    Am J Emerg Med; 2019 Apr; 37(4):798.e3-798.e5. PubMed ID: 30770242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with digoxin immune Fab (ovine) in patients with renal impairment.
    Wenger TL
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):21-3; discussion 33-4. PubMed ID: 1997017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of severe digoxin intoxication with antidote].
    Houlberg E; Blicher TM
    Ugeskr Laeger; 2008 Oct; 170(42):3339. PubMed ID: 18940174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
    Chan BS; Isbister GK; O'Leary M; Chiew A; Buckley NA
    Clin Toxicol (Phila); 2016 Jul; 54(6):488-94. PubMed ID: 27118413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Focus on digitalis intoxication in the elderly. Report of a case treated with digoxin-specific Fab antibody fragments].
    Pautas É; Lopez C; Gouronnec A; Gravelaine S; Peyron I; Lapostolle F
    Geriatr Psychol Neuropsychiatr Vieil; 2012 Dec; 10(4):355-63. PubMed ID: 23250015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition and management of digitalis intoxication: implications for emergency medicine.
    Bayer MJ
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):29-32; discussion 33-4. PubMed ID: 1997019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
    Milani L; Bizzaro N; Sanson A
    G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding digoxin use in the elderly patient.
    Tsang P; Gerson B
    Clin Lab Med; 1990 Sep; 10(3):479-92. PubMed ID: 2253445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.